Tricuspid Valve Regurgitation after Orthotopic Heart Transplantation: Prevalence and Etiology

Table 4

Clinical outcomes of late significant (at least mild-moderate) TR.

Clinical outcome	No TR/mild TR; (𝑛=140)	At least mild-moderate TR; (𝑛=23)	𝑃 value
Mortality (% patients)	28.6%	47.8%	0.065
Median serum creatinine at the end of followup (mg/dL)*	1.4 (0.5–10.4)	1.8 (1.0–2.9)	0.081
Need for diuretic therapy ≥ 10 mg furosemide/day (% patients)	10.4%	47.1%	<0.001
Need for another heart surgery	1.7%	33.3%	<0.001

TR: tricuspid regurgitation.
* Data are presented as median and range (min–max).